BioXcel Therapeutics (BTAI) Long-Term Debt Issuances (2022)
BioXcel Therapeutics has reported Long-Term Debt Issuances over the past 1 years, most recently at $30.0 million for Q3 2022.
BioXcel Therapeutics has reported Long-Term Debt Issuances over the past 1 years, most recently at $30.0 million for Q3 2022.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month